Your browser doesn't support javascript.
loading
Chromosome conformation signatures define predictive markers of inadequate response to methotrexate in early rheumatoid arthritis.
Carini, Claudio; Hunter, Ewan; Ramadass, Aroul S; Green, Jayne; Akoulitchev, Alexandre; McInnes, Iain B; Goodyear, Carl S.
Affiliation
  • Carini C; Pfizer Inc., Cambridge, USA. claudio.carini@kcl.ac.uk.
  • Hunter E; Department of Asthma, Allergy & Lung Biology, GSTT Campus, King's College School of Medicine, London, UK. claudio.carini@kcl.ac.uk.
  • Green J; Oxford BioDynamics Plc, Oxford, UK.
  • Akoulitchev A; Oxford BioDynamics Plc, Oxford, UK.
  • McInnes IB; Oxford BioDynamics Plc, Oxford, UK.
  • Goodyear CS; Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK.
J Transl Med ; 16(1): 18, 2018 01 29.
Article in En | MEDLINE | ID: mdl-29378619

Full text: 1 Database: MEDLINE Main subject: Arthritis, Rheumatoid / Biomarkers / Methotrexate / Chromosomes, Human Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Transl Med Year: 2018 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Main subject: Arthritis, Rheumatoid / Biomarkers / Methotrexate / Chromosomes, Human Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Transl Med Year: 2018 Type: Article Affiliation country: United States